<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00173433</url>
  </required_header>
  <id_info>
    <org_study_id>9461700627</org_study_id>
    <nct_id>NCT00173433</nct_id>
  </id_info>
  <brief_title>Exogenous Reinfection of Tuberculosis in Taiwan</brief_title>
  <official_title>The Importance of Exogenous Reinfection in the Tuberculosis Endemic of Taiwan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <brief_summary>
    <textblock>
      we hypothesize that exogenous reinfection is very important in the Taiwan endemic. Therefore,
      we design a series of studies to evaluate the individual contribution of exogenous
      reinfection and endogenous reactivation in the Taiwan endemic, and to realize the impact of
      exogenous reinfection. First, we will identify the patients with TB relapse after complete
      treatment. The M. tuberculosis isolates responsible for their initial and recurrent episodes
      will then be genotyped to clarify the percentage of exogenous reinfection and endogenous
      reinfection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tuberculosis (TB) remains the most important infectious disease in the world. In Taiwan, the
      incidence of TB increased in recent years. The failure of control implies the necessity to
      reevaluate the epidemiology of Mycobacterium tuberculosis. It is widely thought that most
      cases of TB are caused by reactivation of a latent infection. Treatment programs have
      therefore focused on cure rates rather than tracking of additional cases. But recent studies
      showed that exogenous reinfection plays an important role in the development of TB. In
      addition, it seems that the higher the local incidence, the more important exogenous
      reinfection is. The question of exogenous reinfection versus endogenous reactivation has an
      impact on the distribution of resources for the prevention and treatment of TB. Based on
      these evidences, we hypothesize that exogenous reinfection is very important in the Taiwan
      endemic. Therefore, we design a series of studies to evaluate the individual contribution of
      exogenous reinfection and endogenous reactivation in the Taiwan endemic, and to realize the
      impact of exogenous reinfection. First, we will identify the patients with TB relapse after
      complete treatment. The M. tuberculosis isolates responsible for their initial and recurrent
      episodes will then be genotyped to clarify the percentage of exogenous reinfection and
      endogenous reinfection.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">July 2006</completion_date>
  <primary_completion_date type="Actual">July 2006</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>relapse due to reinfection</measure>
    <time_frame>6 years</time_frame>
    <description>proportion of patients with exogenous reinfection in those with relapse of TB</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Tuberculosis</condition>
  <arm_group>
    <arm_group_label>Culture-confirmed relapse of TB</arm_group_label>
    <description>Patients who have a recurrent episode of culture-confirmed TB after completion of treatment for the first episode of culture-confirmed TB</description>
  </arm_group>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  culture-proven tuberculosis with recurrence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jann-Yuan Wang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Bandera A, Gori A, Catozzi L, Degli Esposti A, Marchetti G, Molteni C, Ferrario G, Codecasa L, Penati V, Matteelli A, Franzetti F. Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J Clin Microbiol. 2001 Jun;39(6):2213-8.</citation>
    <PMID>11376059</PMID>
  </reference>
  <reference>
    <citation>Behr MA, Warren SA, Salamon H, Hopewell PC, Ponce de Leon A, Daley CL, Small PM. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet. 1999 Feb 6;353(9151):444-9. Erratum in: Lancet 1999 May 15;353(9165):1714.</citation>
    <PMID>9989714</PMID>
  </reference>
  <reference>
    <citation>Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, Jasmer RM, Koppaka V, Menzies RI, O'Brien RJ, Reves RR, Reichman LB, Simone PM, Starke JR, Vernon AA; American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003 Feb 15;167(4):603-62.</citation>
    <PMID>12588714</PMID>
  </reference>
  <reference>
    <citation>Caminero JA, Pena MJ, Campos-Herrero MI, Rodríguez JC, Afonso O, Martin C, Pavón JM, Torres MJ, Burgos M, Cabrera P, Small PM, Enarson DA. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):717-20.</citation>
    <PMID>11254530</PMID>
  </reference>
  <reference>
    <citation>Caminero JA, Pena MJ, Campos-Herrero MI, Rodríguez JC, García I, Cabrera P, Lafoz C, Samper S, Takiff H, Afonso O, Pavón JM, Torres MJ, van Soolingen D, Enarson DA, Martin C. Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island. Am J Respir Crit Care Med. 2001 Oct 1;164(7):1165-70.</citation>
    <PMID>11673204</PMID>
  </reference>
  <reference>
    <citation>Cronin WA, Golub JE, Lathan MJ, Mukasa LN, Hooper N, Razeq JH, Baruch NG, Mulcahy D, Benjamin WH, Magder LS, Strickland GT, Bishai WR. Molecular epidemiology of tuberculosis in a low- to moderate-incidence state: are contact investigations enough? Emerg Infect Dis. 2002 Nov;8(11):1271-9.</citation>
    <PMID>12453355</PMID>
  </reference>
  <reference>
    <citation>Davies BH. Infectivity of tuberculosis. Thorax. 1980 Jul;35(7):481-2.</citation>
    <PMID>7434308</PMID>
  </reference>
  <reference>
    <citation>Ellis BA, Crawford JT, Braden CR, McNabb SJ, Moore M, Kammerer S; National Tuberculosis Genotyping and Surveillance Network Work Group. Molecular epidemiology of tuberculosis in a sentinel surveillance population. Emerg Infect Dis. 2002 Nov;8(11):1197-209.</citation>
    <PMID>12453343</PMID>
  </reference>
  <reference>
    <citation>Garbe TR, Hibler NS, Deretic V. Isoniazid induces expression of the antigen 85 complex in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1996 Jul;40(7):1754-6.</citation>
    <PMID>8807080</PMID>
  </reference>
  <reference>
    <citation>García de Viedma D, Marín M, Hernangómez S, Díaz M, Ruiz Serrano MJ, Alcalá L, Bouza E. Tuberculosis recurrences: reinfection plays a role in a population whose clinical/epidemiological characteristics do not favor reinfection. Arch Intern Med. 2002 Sep 9;162(16):1873-9.</citation>
    <PMID>12196086</PMID>
  </reference>
  <reference>
    <citation>Glassroth J, Robins AG, Snider DE Jr. Tuberculosis in the 1980s. N Engl J Med. 1980 Jun 26;302(26):1441-50. Review.</citation>
    <PMID>6990260</PMID>
  </reference>
  <reference>
    <citation>Jou NT, Yoshimori RB, Mason GR, Louie JS, Liebling MR. Single-tube, nested, reverse transcriptase PCR for detection of viable Mycobacterium tuberculosis. J Clin Microbiol. 1997 May;35(5):1161-5.</citation>
    <PMID>9114400</PMID>
  </reference>
  <reference>
    <citation>Miller AC, Sharnprapai S, Suruki R, Corkren E, Nardell EA, Driscoll JR, McGarry M, Taber H, Etkind S. Impact of genotyping of Mycobacterium tuberculosis on public health practice in Massachusetts. Emerg Infect Dis. 2002 Nov;8(11):1285-9.</citation>
    <PMID>12453357</PMID>
  </reference>
  <reference>
    <citation>Pai SR, Actor JK, Sepulveda E, Hunter RL Jr, Jagannath C. Identification of viable and non-viable Mycobacterium tuberculosis in mouse organs by directed RT-PCR for antigen 85B mRNA. Microb Pathog. 2000 Jun;28(6):335-42.</citation>
    <PMID>10839970</PMID>
  </reference>
  <reference>
    <citation>Sharnprapai S, Miller AC, Suruki R, Corkren E, Etkind S, Driscoll J, McGarry M, Nardell E. Genotyping analyses of tuberculosis cases in U.S.- and foreign-born Massachusetts residents. Emerg Infect Dis. 2002 Nov;8(11):1239-45.</citation>
    <PMID>12453348</PMID>
  </reference>
  <reference>
    <citation>Sokolove PE, Mackey D, Wiles J, Lewis RJ. Exposure of emergency department personnel to tuberculosis: PPD testing during an epidemic in the community. Ann Emerg Med. 1994 Sep;24(3):418-21.</citation>
    <PMID>8080139</PMID>
  </reference>
  <reference>
    <citation>Stead WW. Management of health care workers after inadvertent exposure to tuberculosis: a guide for the use of preventive therapy. Ann Intern Med. 1995 Jun 15;122(12):906-12. Review.</citation>
    <PMID>7755225</PMID>
  </reference>
  <reference>
    <citation>Supply P, Mazars E, Lesjean S, Vincent V, Gicquel B, Locht C. Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol Microbiol. 2000 May;36(3):762-71.</citation>
    <PMID>10844663</PMID>
  </reference>
  <reference>
    <citation>van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993 Feb;31(2):406-9.</citation>
    <PMID>8381814</PMID>
  </reference>
  <reference>
    <citation>van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, Beyers N, van Helden PD. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med. 1999 Oct 14;341(16):1174-9.</citation>
    <PMID>10519895</PMID>
  </reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <last_update_submitted>December 8, 2014</last_update_submitted>
  <last_update_submitted_qc>December 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tuberculosis</keyword>
  <keyword>relapse</keyword>
  <keyword>reinfection</keyword>
  <keyword>reactivation</keyword>
  <keyword>dormancy</keyword>
  <keyword>tuberculin skin test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

